Anthem Biosciences IPO Will Open On July 14, 2025 And Close On July 16, 2025.The ₹3,395 Cr. IPO Is A Book Build Issue, Consisting Entirely of A Fresh Issue and offer for Sale . Anthem Biosciences IPO Price Band Is Set At 540 to ₹570 Per Share.
The Allotment will Be Finalized On July 17, 2025 and Listing date is Expected on The NSE BSE By 21, Jul 2025. Investor Quota like 50% QIB, 35% Retail, and 15% HNI Category.
Financial Year 2025 Company Posted a Revenue of ₹1,930.29 Cr. and A Net Profit of ₹451.26 Cr. Showing Strong Growth From The Previous Year. Based On Financial, The IPO Looks Promising For Long-term Investors.
About Anthem Biosciences Limited
Our Company was originally incorporated on June 13, 2006 “Anthem Biosciences Limited” We are an innovation-driven and technology-focused Contract Research, Development and Manufacturing Organization (“CRDMO”) with fully integrated operations spanning across drug discovery, development and manufacturing.
We are one of the few companies in India with integrated New Chemical Entity (“NCE”) and New Biological Entity (“NBE”) capabilities across drug discovery, development, and commercial manufacturing.
As a one-stop service provider, we serve a range of customers, encompassing innovator-focused emerging biotech and large pharmaceutical companies globally.
We are one of the youngest Indian CRDMO companies and the fastest Indian CRDMO among the assessed peers to achieve a milestone of ₹10,000 million of revenue within 14 years of operations, reaching this milestone in Fiscal 2021.
we have completed over 8,000 unique programs commissioned by our customers (“Projects”) and worked on molecules with more than 675 customers at various stages of the drug development lifecycle under our CRDMO business.
Anthem Biosciences IPO Dates & Price Band Details
| IPO Open Date | July 14, 2025 |
|---|---|
| IPO Close Date | July 16, 2025 |
| IPO Price Band | ₹540 to ₹570 per share |
| Face Value | ₹2 per equity share |
| Lot Size | 26 Shares |
| Minimum Investment | ₹14,820 Thousand (for 1 lot at ₹570) |
| IPO Issue Type | Book Built Issue |
| IPO Issue Size | 5,95,61,403 shares (Approx ₹3,395 Cr) |
| Fresh Issue | - |
| Offer For Sale | 5,95,61,403 shares (Approx ₹3,395 Cr) |
| Employees Discount | ₹50 per equity share |
| Retail Investor Quota | 35% |
| QIB Quota | 50% |
| NII (HNI) Quota | 15% |
| Listing Exchange | NSE BSE |
| Anchor Investor List | Click Here |
| DRHP (Draft Prospectus) | Click Here |
| RHP (Final Prospectus) | Click Here |
Anthem Biosciences IPO Market Lot Size
The Minimum Lot Size For The Anthem Biosciences IPO is 26 Shares, Requiring An Application Amount of ₹14,820 For Retail Investors. Investors Must Apply in Multiples of The Lot Size.
| Application | Lot Size | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 1 | 26 | ₹14,820 |
| Retail Maximum | 13 | 338 | ₹1,92,660 |
| S-HNI Minimum | 14 | 364 | ₹2,07,480 |
| B-HNI Minimum | 68 | 1,768 | ₹10,07,760 |
Objects Of The Issue
NA
Anthem Biosciences IPO Allotment & Listing Dates
Anthem Biosciences IPO Will Open on July 14 and Close on July 16, 2025. The allotment is Expected on July 17, With the Listing Scheduled on NSE BSE For Jul 21, 2025 (More information below table).
| Anchor Investor Bidding | July 11, 2025 |
|---|---|
| IPO Opens | July 14, 2025 |
| IPO Closes | July 16, 2025 |
| Allotment Finalisation | July 17,2025 |
| Refunds / Unblocking | July 18,2025 |
| Shares Credited to Demat | July 18,2025 |
| Listing Date | July 21,2025 |
Anthem Biosciences IPO Financial Report (FY 2025)
Anthem Biosciences Reported a total Revenue of ₹1,930.29 Cr. in FY 2025, Slightly up From ₹1,483.07 Cr. in FY 2024. The Company Net Profit Also Rose to ₹451.26 Cr. From ₹367.31 Cr. in the Previous Year Showing Consistent Financial Growth Ahead of its IPO. (More information below table).
Period Ended
31 Mar 2025
31 Mar 2024
31 Mar 2023
Assets
4,650.85
4,147.08
4,473.50
Revenue
1,409.67
1,113.11
744.07
Profit After Tax
-63.18
-49.96
-101.05
EBITDA
857.26
659.67
424.00
Net Worth
107.51
50.01
31.47
Reserves and Surplus
4.69
29.01
-46.23
Total Borrowing
397.77
427.35
515.39
Amount in ₹ Crore
Anthem Biosciences IPO Valuation Report – FY 2025 (KPI)
Check Detailed Anthem Biosciences IPO Valuation Metrics for FY 2025, including EPS, P/E Ratio, RoNW, NAV, ROCE, and other key financial indicators. These Ratios help Investors Assess the Company financial Health & Valuation Before applying for The IPO. (More information below table).
| KPI | Value |
|---|---|
| Return on Equity (ROE) | 20.82% |
| Return on Capital Employed (ROCE) | 26.88% |
| EBITDA Margin | 36.81% |
| PAT Margin | 23.38% |
| Debt-to-Equity Ratio | 0.05 |
| Earnings Per Share (EPS) | 8.07 |
| Price to Earnings Ratio (P/E) | 70.63 |
| Return on Net Worth (RoNW) | 20.82% |
| Net Asset Value (NAV) | 43.10 |
Qualitative Factors
- We offer comprehensive one-stop service capabilities across the drug life cycle (drug discovery, development and manufacturing) for both small molecules and biologics and we are the fastest growing Indian CRDMO.
- Our innovation-focused approach has enabled us to offer a spectrum of technologically advanced solutions across modalities and manufacturing practices.
- Differentiated business model catering to the needs of small pharmaceutical and emerging biotech companies, from discovery to commercial manufacturing.
- Long-standing relationships with a large, diversified and loyal customer base.
- Wide specialty ingredients portfolio, well positioned to capitalize on the large market opportunity for niche specialty ingredients such as GLP-1, fermentation-based products, probiotics, enzymes, nutritional actives, vitamin analogues and biosimilars.
- Fully built-out automated manufacturing infrastructure with a consistent regulatory compliance track record.
- Demonstrated industry-leading growth, profitability and capital efficiency from Fiscal 2024 to Fiscal 2025 alongside a robust growth pipeline.
- Professional and experienced leadership team supported by a qualified scientific talent pool.
Our Company Promoters
- Ajay Bhardwaj
- Ganesh Sambasivam
- K Ravindra Chandrappa
- Ishaan Bhardwaj
Comparison With Industry Peers
| Name of the Company | Face Value (Per share) | CMP July 7, 2025 | EPS (Rs) | P/E Ratio | RONW (%) | NAV (Rs. Per share) | Total revenue (in ₹ million) |
|---|---|---|---|---|---|---|---|
| Anthem Bioscienc es Limited | 2.00 | - | 8.07 | 70.63 | 20.82 | 43.10 | 18,445.53 |
| Syngene Internatio nal Limited | 10.00 | 635.95 | 12.35 | 51.54 | 11.05 | 117.42 | 36,424.00 |
| Sai Life Sciences Limited | 1.00 | 793.70 | 8.83 | 92.18 | 10.96 | 102.12 | 16,945.70 |
| Cohance Lifescienc es Limited | 1.00 | 1,016.70 | 10.52 | 97.29 | 13.61 | 72.31 | 11,975.80 |
| Divi’s Laboratori es Limited | 2.00 | 6,868.50 | 82.53 | 83.22 | 15.35 | 564.87 | 93,600.00 |
Also Read – Anthem Biosciences IPO GMP Today, Grey Market Premium Live
Anthem Biosciences Company Contact Details
Office: No. 49, F1 & F2, Canara Bank Road,
Bommasandra Industrial Area, Phase 1,
Bommasandra, Bangalore,
Karnataka, India, 560 099;
Telephone: +91 080 6672 4000
E-mail: investors.abl@anthembio.com
Website: www.anthembio.com
Anthem Biosciences Lead Manager
JM Financial Limited
7th Floor, Cnergy, Appasaheb Marathe Marg,
Prabhadevi, Mumbai 400 025, Maharashtra,India
Telephone: +91 22 6630 3030
E-mail: Anthem.ipo@jmfl.com
Website: www.jmfl.com
Citigroup Global Markets India Pvt Ltd
1202, 12th Floor, First International Financial
Centre G-BlockBandra Kurla Complex Bandra (East),
Mumbai 400 098 Maharashtra, India
Telephone: +91 22 6175 9999
E-mail: anthem.ipo@citi.com
Website: https://www.citigroup.com
J.P. Morgan India Private Limited
J.P. Morgan Tower, Off CST Road, Kalina Santacruz
East, Mumbai 400 098 Maharashtra, India
Telephone: +91 22 6157 3000
E-mail: anthem_ipo@jpmorgan.com
Website: www.jpmipl.com
Nomura Financial Advisory and Securities (India) Pvt Ltd
Ceejay House, Level 11, Plot F, Shivsagar Estate,
Dr. Annie Besant Road, Worli, Mumbai 400
018, Maharashtra, India
Telephone: +91 22 4037 4037
E-mail: anthembioipo@nomura.com
Website: www.nomuraholdings.com
Anthem Biosciences IPO Registrar
KFin Technologies Limited
Selenium, Tower B, Plot No- 31 and 32, Financial
District, Nanakramguda, Serilingampally, Hyderabad,
Rangareddy 500 032, Telangana, India
Telephone: +91 40 6716 2222
E-mail: anthem.ipo@kfintech.com
Website: www.kfintech.com
Anthem Biosciences IPO FAQs
Question 1: What is the Anthem Biosciences IPO?
Answer 1: Anthem Biosciences IPO is a Mainboard IPO of 5,95,61,403 equity shares of the face value of ₹2 approximately up to ₹3,395 Cr. The issue is price at ₹540 to ₹570 per share.
The Anthem Biosciences IPO opens on 14 July 2025 and closes on 16 July 2025.
KFin Technologies Limited is the registrar for the IPO. The shares to be listed on NSE BSE.
Question 2: How to apply in Anthem Biosciences IPO through Groww?
Answer 2: Groww customers can apply online in Anthem Biosciences IPO using UPI as a payment gateway. Groww customers can apply in Anthem Biosciences IPO by login into Groww (back office) and submitting an IPO application form.
Steps to apply in Anthem Biosciences IPO through Groww –
- Visit the Groww website and login to Groww.
- Go to Main Page and click the Products & tools and click IPO tab.
- New page Open and Show ‘Anthem Biosciences IPO’ click the ‘Apply’ button.
- Show IPO detail Shares lot Size and Bid Price & click here to Cutoff Price check Box and Continue.
- Inter Your UPI id like . 95****299@kotak accept terms and condition click Box and Apply For IPO
- groww share payment link Your UPI Mobile Number Pay Payment for IPO Bid to approve the e-mandate successfully submit application .
Question 3: When Anthem Biosciences IPO will open?
Answer 3: The Anthem Biosciences IPO opens on July 14, 2025 and closes on July 16, 2025.
Question 4: What is the lot size of Anthem Biosciences IPO?
Answer 4: Anthem Biosciences IPO lot size and the minimum order quantity is 26 Shares.
Question 5: How to apply for Anthem Biosciences IPO?
Answer 5: You can apply in Anthem Biosciences IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don’t offer banking services. Read more detail about applying IPO online through Groww, Zerodha, Upstox, 5Paisa, Phonepe Share Market, HDFC Bank, and Angel one.
Question 6: When is Anthem Biosciences IPO allotment date?
Answer 6: The Basis of Allotment for Anthem Biosciences IPO will be on Tuesday, 17 July 2025, and the allotted shares will be credited to your demat account by , 18 July 2025. For Check the Anthem Biosciences IPO allotment status.
Question 7: When is Anthem Biosciences IPO listing date?
Answer 7: The Anthem Biosciences IPO listing date is 21 July 2025. The date of Anthem Biosciences IPO listing on Monday 21, Jul 2025.
1 thought on “Anthem Biosciences IPO 2025, Date, GMP, Price, Allotment, Review & Listing”